Cardiovascular Systems Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cardiovascular Systems are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cardiovascular Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Cardiovascular Systems is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 71.1 M | |
| Total Cashflows From Investing Activities | 22.2 M |
Cardiovascular |
Cardiovascular Systems Relative Risk vs. Return Landscape
If you would invest (100.00) in Cardiovascular Systems on November 11, 2025 and sell it today you would earn a total of 100.00 from holding Cardiovascular Systems or generate -100.0% return on investment over 90 days. Cardiovascular Systems is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Cardiovascular, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cardiovascular Systems Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cardiovascular Systems for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cardiovascular Systems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cardiovascular Systems is not yet fully synchronised with the market data | |
| Cardiovascular Systems has some characteristics of a very speculative penny stock | |
| Cardiovascular Systems has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 236.22 M. Net Loss for the year was (36.93 M) with profit before overhead, payroll, taxes, and interest of 172.78 M. | |
| Cardiovascular Systems currently holds about 159.83 M in cash with (24.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.9. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies |
Cardiovascular Systems Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cardiovascular Stock often depends not only on the future outlook of the current and potential Cardiovascular Systems' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardiovascular Systems' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.2 M | |
| Cash And Short Term Investments | 159.8 M |
Cardiovascular Systems Fundamentals Growth
Cardiovascular Stock prices reflect investors' perceptions of the future prospects and financial health of Cardiovascular Systems, and Cardiovascular Systems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cardiovascular Stock performance.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Price To Earning | 724.24 X | |||
| Price To Book | 2.43 X | |||
| Price To Sales | 2.51 X | |||
| Revenue | 236.22 M | |||
| EBITDA | (29.96 M) | |||
| Cash And Equivalents | 159.83 M | |||
| Cash Per Share | 3.90 X | |||
| Total Debt | 22.15 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 5.70 X | |||
| Cash Flow From Operations | (24.27 M) | |||
| Earnings Per Share | (0.96) X | |||
| Total Asset | 322.68 M | |||
| Retained Earnings | (320 M) | |||
| Current Asset | 104.88 M | |||
| Current Liabilities | 35.5 M | |||
Things to note about Cardiovascular Systems performance evaluation
Checking the ongoing alerts about Cardiovascular Systems for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cardiovascular Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cardiovascular Systems is not yet fully synchronised with the market data | |
| Cardiovascular Systems has some characteristics of a very speculative penny stock | |
| Cardiovascular Systems has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 236.22 M. Net Loss for the year was (36.93 M) with profit before overhead, payroll, taxes, and interest of 172.78 M. | |
| Cardiovascular Systems currently holds about 159.83 M in cash with (24.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.9. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Cardiovascular Systems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cardiovascular Systems' stock is overvalued or undervalued compared to its peers.
- Examining Cardiovascular Systems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cardiovascular Systems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cardiovascular Systems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cardiovascular Systems' stock. These opinions can provide insight into Cardiovascular Systems' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |